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Abstract
Background Context: Spinal manipulation (SM) is a common treatment for neck and back pain, theorized to mechanically affect the spine leading to therapeutic mechanical changes. The link between specific mechanical effects and clinical improvement is not well supported. SM's therapeutic action may instead be partially mediated within the central nervous system.
Purpose: To introduce brain-based models of pain for spinal pain and manual therapy research, characterize the central mechanisms of SM, and advance the validation of brain-based models as potential clinical biomarkers of pain.
Study Design: Secondary analysis of two functional magnetic resonance imaging studies investigating the effect of thoracic SM on pain-related brain activity: A non-controlled, non-blinded study in healthy volunteers (Study 1, n = 10, 5 females, and mean age = 31.2 ± 10.0 years) and a randomized controlled study in individuals with acute to subacute neck pain (Study 2, n = 24, 16 females, mean age = 38.0 ± 15.1 years).
Methods: Functional magnetic resonance imaging was performed during noxious mechanical stimulation of the right index finger cuticle pre-and post-intervention. The effect of SM on painrelated activity was studied within brain regions defined by the Neurologic Pain Signature (NPS) that are predictive of physical pain.
Results: In Study 1, evoked mechanical pain (p < 0.001) and NPS activation (p = 0.010) decreased following SM, and the changes in evoked pain and NPS activation were correlated (r RM 2 = 0.418, p = 0.016). Activation within the NPS subregions of the dorsal anterior cingulate cortex (dACC, p =
Introduction
Spinal pain is a leading cause of disability, affecting nearly one billion individuals worldwide [1] [2] [3] [4] . A challenge in the clinical management of spinal pain is the lack of diagnostic, prognostic, and predictive information to determine which therapy or combination of therapies is most appropriate for an individual patient at a given time. A more nuanced understanding of the neurobiology of spinal pain, the therapeutic action of treatments, and the factors shaping the individual pain experience and treatment response may help realize a new era of patient-centric rehabilitation.
Spinal manipulation (SM) is a common treatment for spinal pain with guideline support when combined with education and exercise [5] [6] [7] [8] [9] [10] . SM is characterized by a mechanical thrust to spinal joints slightly beyond their passive range of motion [11] . SM's clinical rationale has long been guided by the opinion that a mechanical effect on the spine leads to therapeutic mechanical changes [12] . However, a purely biomechanical mechanism remains debatable as studies have failed to link specific mechanical effects to meaningful clinical improvement [13, 14] . SM's therapeutic action may instead be partially mediated within the central nervous system (CNS) [15, 16] .
Pain is a subjective, psychological phenomenon influenced by multiple physiological and cognitive processes [17] . Clinicians rely mainly on self-reported pain, which is limited by the patient's ability to report his/her pain experience, and may not provide information on the source of pain, its projected natural history, or the proper treatment direction [18] [19] [20] . The development of objective pain biomarkers to complement self-report is of increasing interest [21] . Functional MRI (fMRI) has had a central role in this effort by mapping pain processing in the CNS, revealing that the perception of pain is not encoded by a single brain area but distributed throughout the brain [22] .
The complexity of the pain network makes drawing conclusions on the role of any specific brain region challenging. Higher-level approaches are required to extract meaningful information from the patterns of brain activity. Multivariate pattern analysis and machine-learning techniques are allowing researchers to develop brain-based predictive models of pain that may become valuable biomarkers [23] [24] [25] . In addition to being diagnostic, prognostic, and predictive tools, these approaches can characterize normal and abnormal processes, increasing our mechanistic understanding of pain and identifying new treatment targets [26, 27] .
Here, we perform a secondary analysis of two fMRI studies investigating the effect of thoracic SM on pain-related brain activity. We leverage these datasets and a multivariate brainbased model of physical pain, the Neurologic Pain Signature (NPS), to explore the effect of SM on activity within brain regions predictive of physical pain [28] . Our purpose is threefold: 1) To introduce brain-based models of pain for spinal pain and manual therapy research, 2) To characterize the distributed central mechanisms of SM, and 3) To advance the preliminary validation of brain-based models as potential clinical biomarkers of pain. We hypothesize that NPS activation and perceived pain will decrease following SM, and we expect the NPS activation to be positively correlated to pain.
Materials and Methods

Participants and Location
De-identified datasets were obtained from two previously published fMRI studies that investigated changes in pain-related brain activity following thoracic SM using univariate analyses [29, 30] . The study location, equipment, imaging parameters, and stimulus (location and intensity)
were the same across the studies. Study 1 was a non-controlled, non-blinded study in healthy volunteers receiving verum SM only (n = 10). Study 2 utilized a randomized, controlled study design in participants with acute or subacute neck pain (ClinicalTrials.gov Identified:
NCT01862705) [30] . The participants received either verum (n = 12) or sham (n = 12) SM, and the participants and assessor were blinded to the intervention. The inclusion and exclusion criteria for both studies are summarized in Table 1 . The studies were conducted at OSF HealthCare Saint Francis Medical Center (Peoria, IL, USA). The Institutional Review Board at the University of Illinois
College of Medicine (Peoria, IL, USA) approved both study protocols. Prior to enrollment, the study procedures and risks were discussed with each participant, and then written informed consent was obtained.
Noxious Mechanical Stimulation
To study the effect of SM on pain-related brain activity, noxious mechanical stimuli were applied manually to the cuticle of the right index finger with von Frey filaments. Several studies have used a similar combination of von Frey filaments and fMRI to study central mechanisms of pain processing [31] [32] [33] . In Study 1, participants underwent a pain thresholding procedure on the day prior to imaging in which a graduated succession of filaments (starting filament 2.83 size (0.07 g)) were applied in 5 s durations with a 20 s interstimulus interval. The pain threshold was defined as the least intensity stimulus at which the stimulus changed from pressure to pain. The 6.65 size (300 g) von Frey filament elicited pain in every participant and was therefore used as the stimulus intensity for functional imaging in Study 1. The same stimulus intensity was also used in Study 2.
Functional imaging was performed in 5 minute runs during alternating 15 s blocks of noxious mechanical stimulation of the right index finger cuticle and no stimulation pre-and postintervention. During the stimulation blocks, the stimuli were applied manually at 1 Hz. The stimulation protocol is designed to elicit temporal summation of second pain (TSSP). TSSP is the human analog to the animal "wind-up" phenomenon and is hypothesized to be centrally mediated [34] . Following each run, participants rated the intensity of index finger stimulus using the 11-point numerical pain rating scale (NPRS) with anchors of no pain (0) and worst imaginable pain (10) . In Study 2, participants also used the NPRS to rate their neck pain at baseline and pre-and postintervention, and the investigator administering the stimuli and assessing the evoked pain and neck pain intensity was blinded to treatment assignment. Functional imaging was also performed during noxious mechanical stimulation of the right great toe before and after the intervention in Study 2;
however, since the right great toe stimulation protocol was not performed in Study 1, these findings were not included in the present analysis but have been reported previously in Sparks et al. (2017) [30] . The great toe stimulation was performed in separate functional imaging runs from the index finger stimulation, and the index finger stimulation runs always preceded the great toe stimulation.
Image Acquisition
Imaging was performed on a 3T Signa HDx General Electric magnetic resonance scanner equipped with an 8-channel head coil (General Electric, Milwaukee, Wisconsin, USA). Participants were placed supine on the scanner bed in a hook-lying position with a foam bolster under the knees. Ear plugs were provided to attenuate the scanner noise, and foam pads were used to secure the head and minimize participant motion during scanning. For spatial normalization of the functional images to template space, a high-resolution T 1 -weighted structural image of the whole brain was initially obtained using a three-dimensional fast spoiled gradient-echo sequence without 
Spinal Manipulation
Participants received a single session of either verum (Studies 1 and 2) or sham (Study 2) thoracic SM immediately following the pre-intervention functional imaging. Thoracic SM is commonly used in the treatment of non-specific neck pain with effectiveness similar to cervical SM [35] [36] [37] . In Study 2, participants were randomly assigned to the verum or sham intervention using a computer-generated sequence. The SM procedure was performed without repositioning the participant on the scanner table or removing the participant from the head coil. The verum SM intervention consisted of a high-velocity low amplitude, end-range force applied manually along an anterior-to-posterior vector through the elbows and directed to the mid-thoracic spine [38, 39] . To accomplish this, the experimenter's manipulative hand was used to stabilize the inferior vertebra of the targeted motion segment (approximately the T4-5 motion segment), and the experimenter used her body weight to push down through the participant's arms. For the sham intervention, the experimenter's hands were placed in the same position as the verum intervention; however, the investigator's hands slid across the skin with minimal pressure to mimic the contact in the verum intervention, but no counterforce or thrust was directed toward the motion segment. The sham SM procedure has been demonstrated to be a valid sham compared to verum SM targeting the thoracic region [40] . The time from the end of the pre-intervention functional imaging run to the start of the post-intervention run was less than 5 minutes.
First-Level Analysis
Image processing and statistical analysis of the functional images were performed using the 
Statistical Analysis
As our a priori hypotheses were directional, one-tailed statistical tests were performed to investigate the effect of time (pre-and post-intervention) on evoked pain, NPS activation, and, in Study 2 only, neck pain. All other analyses were performed using two-tailed tests, which included the exploratory analysis of activation within the different NPS subregions. Repeated measures correlations (RMCORR) were performed to assess associations between the clinical measures and NPS activation pre-and post-intervention. RMCORR estimates the common regression slope (i.e., fixed slopes and varying intercepts) to quantify the association shared among the participants without aggregation of the repeated measures or violation of the assumption of independence of observations and has been reported to have increased statistical power [47] . [48, 49] .
Results
All participants completed the entire study protocol with no reported adverse events, and no data were excluded from the analyses. Participant motion during functional imaging was very low.
The mean absolute and mean relative displacements were < 0.5 mm for all participants and runs.
Age and gender did not statistically differ between the groups. Baseline evoked pain was significantly lower for the Study 2 Verum SM group compared to the Study 1 Verum SM group (two-tailed independent samples t-test, t = 3.468, p = 0.002) and Study 2 Sham SM group (t = 2.845, p = 0.010), indicating that while the same stimulus intensity was used for each participant, the evoked pain was not matched across the groups ( Table 2) .
Study 1: Healthy
Evoked pain (mean ± standard error (SE)) significantly decreased from 4.50 ± 0.34 to 2.30 ± 0.34 post-intervention (one-tailed paired samples t-test, t = 11.000, p < 0.001). NPS activation (mean ± SE) also significantly decreased from 1,760.17 ± 201.79 to 1,174.60 ± 112.42 postintervention (one-tailed paired samples t-test, t = 2.826, p = 0.010) (Fig. 2) . Within the NPS positive subregions, the rS2_Op (two-tailed paired samples t-test, t = 2.320 p = 0.045) and dACC (t = 3.130 p = 0.012) activation significantly decreased post-intervention. Fig. 3 ). NPS activation was strongly correlated to evoked pain (one-tailed RMCORR, r RM = 0.647, p = 0.016). Within the NPS subregions showing significant changes, dACC activation was also strongly correlated to evoked pain (two-tailed RMCORR, r RM = 0.691, p = 0.019) while rS2_Op activation tended to be moderately correlated to evoked pain (r RM = 0.588, p = 0.057) ( Fig. 4) . and pgACC) activation, evoked pain, and neck pain were explored in the verum SM group. While no significant correlations were present, the NPS activation tended to be weakly correlated to neck pain (one-tailed RMCORR, r RM = 0.369, p = 0.107) ( Fig. 7 ).
Discussion
We provide evidence for decreased NPS activation following thoracic SM. First in a noncontrolled, non-blinded study of healthy volunteers (Study 1), we showed that evoked pain intensity, NPS activation, and activation within the NPS positive subregions of the dACC and rS2_Op decreased following SM. Additionally, evoked pain was strongly positively correlated to overall NPS activation and activation within the dACC, further supporting the association between SM-induced changes in evoked pain and NPS activation. The study design, however, prevents drawing any causal conclusions, as experimenter and observer bias, placebo, habituation, and demand characteristics may have confounded the findings. Moreover, the use of healthy controls reduces the ecological validity of the findings, as SM is clinically used for spinal pain. In a randomized controlled trial of neck pain participants (Study 2), we addressed some of these limitations and provide further evidence of decreased NPS activation following verum SM but not sham SM. The associations between changes in NPS activation, evoked pain, and neck pain in this clinical population, however, were not significant and less clear. Despite the limitations discussed below, when taken together, the findings provide evidence that SM may alter painrelated brain activity within brain regions specific to the processing of physical pain, supporting a possible central mechanism of SM and providing further validation of the NPS as a clinical biomarker of pain.
SM-induced changes in evoked pain-related brain activity in Studies 1 and 2 were previously explored using conventional brain mapping approaches [29, 30] . For example in Study 1 using a univariate voxelwise analysis with standard statistical thresholds, evoked-pain activity was mapped to brain areas commonly reported in experimental pain studies including the cerebellum, amygdala, thalamus, periaqueductal gray, insular cortices, anterior cingulate cortex, somatosensory cortices, and supplemental motor and premotor areas. Post-SM activity decreased in the left postcentral and precentral gyri, right supramarginal gyrus, anterior cingulate cortex, right superior parietal lobule, right cerebellum, and right insular cortex [29] . Conventional brain mapping can reveal differences in brain activity due to physiological processes, following treatment, or between groups, aiding in our understanding of brain mechanisms and hypothesis generation. However, the spatial location and extent of activity are dependent on the statistical thresholding employed, and the maps themselves provide no information on the interactions between brain regions or any predictive information, precluding their use as a biomarker. In contrast, brain-based models such as the NPS provide a quantitative measure that can make predictions across individuals and, in the case of the NPS, predict pain.
The NPS was developed by training a multivariate regression model to predict pain intensity from fMRI maps of varying intensity experimental thermal stimuli in healthy volunteers. In independent datasets, the NPS model was shown to track perceived pain intensity, classify between innocuous and painful stimuli, be specific to physical pain versus social pain, and decrease with opioid analgesics [28] . Employing methods similar to the NPS, brain-based models could be developed to predict treatment response using experimental evoked pain maps, clinical pain maps, resting state fMRI measures, or any combination of these features. The predictive brain regions could provide valuable information on the neurobiological mechanisms of treatment and neurobiological state of treatment responders. When building these models, patient expectations should be considered.
Expectations appear to modulate patterns of neural activation and the pain experience in individuals with knee osteoarthritis, and expectations may shape patterns of neural activation as well as the clinical outcomes and experiences of individuals seeking neck pain treatment [69] . In contrast, two recent studies demonstrated that while self-regulation and placebo reduce pain responses, they had little effect on NPS activation, indicating that NPS may be responsive to the primary processing of nociceptive information versus higher level cognitive aspects of the pain experience [53, 70] . These studies, however, used experimental evoked pain in healthy participants, and the findings may not translate to clinical pain conditions. Monitoring treatment expectation should be performed in future studies to explore its influence.
The clinical rationale regarding SM has long been guided by a biomechanical perspective, in which SM is applied to correct aberrant joint mechanics leading to therapeutic mechanical changes in the spine. Links between biomechanical changes and clinical improvements, however, have only been weakly supported in the literature [13, 14] . A growing body of evidence is pointing towards neurophysiologic mechanisms of action underlying the pain modulating effects of SM including both spinal and supraspinal mechanisms [15, 16] . The reduction in NPS activation suggests a decrease in nociceptive information reaching supraspinal areas. SM is known to activate large diameter mechanoreceptors that in turn can inhibit the transmission of nociceptive signals at the spinal cord [71] . Additionally, the activation of descending pain inhibitory pathways could also reduce nociceptive signaling, and the activation of these inhibitory systems may explain how thoracic SM could affect nociceptive processing at more superior cervical spinal cord segments (i.e., right index finger stimulation corresponds to the C7 dermatome) as reported in this study.
Distraction and/or patient expectation for pain relief may further explain the non-segmental effects of SM on pain reduction [72] [73] [74] . Segmental inhibition, descending inhibition, and other supraspinal
processes not yet fully understood, may contribute to the overall therapeutic action of SM [71, 75, 76] . Technical advancements in imaging have made spinal cord fMRI, and, more recently, simultaneous spinal cord-brain fMRI, possible [77] [78] [79] [80] [81] . Such advances may allow us to better characterize spinal and supraspinal patterns of activity, providing a more complete assessment of nociceptive and pain processes and further refinement of the NPS and other neuroimaging-based models of pain [82] . Future work using a better surrogate for imaging the neck pain experience and 
Conclusions
We provide preliminary evidence that SM may alter the processing of pain-related brain activity within specific pain-related brain regions, supporting the use of brain-based models such, as the NPS, as clinical biomarkers of pain. Future work should aim to improve brain-based biomarker models of neck pain for use in larger randomized controlled trials. These biomarkers have potential to allow us to better understand the central mechanisms of SM, predict treatment response, and optimize the delivery of treatment (technique, frequency, and duration). To investigate the effect of SM on evoked mechanical pain-related brain activity, we focused on activation within brain regions predictive of physical pain using the Neurologic Pain Signature (NPS). The NPS is a multivariate brain activation pattern that has been shown to be sensitive and specific to experimentally-evoked pain at the individual level [28] . The NPS activation was calculated by taking the dot product of the NPS pattern weights and the stimulus parameter estimate images from each participant's first-level analysis. The dot product provides a single scalar value to quantify the NPS activation (arbitrary units). activation and tended to be positively correlated to right somatosensory cortex (rS2_Op) activation.
Figure Captions
NPS activation was hypothesized to be positively correlated with evoked pain, so one-tailed tests were performed. Two-tailed tests were performed for the exploratory analysis within the NPS subregions. NPS activation is in arbitrary units. were identified for evoked pain or neck pain in the neck pain participants receiving verum SM, a non-significant positive weak correlation between neck pain and NPS activation (p = 0.107) was present. NPS activation is in arbitrary units. NPS activation was hypothesized to be positively correlated with evoked pain and neck pain, so one-tailed tests were performed. Two-tailed tests were performed for the exploratory analysis within the NPS subregions. rS2_Op=right secondary 
